IIT and Partners

MINDED is led by the Istituto Italiano di Tecnologia (Italian Institute of Technology – IIT) in Genoa (Italy) and involves 16 partners in Europe, Usa and Israel, comprising 11 research centers and universities and 6 non-academic institutions

Istituto Italiano di Tecnologia (IIT)

Prof. Paolo Decuzzi

Prof. Paolo Decuzzi is the coordinator of the MINDED project and the director of the Laboratory of Nanotechnology for Precision Medicine at IIT. The Laboratory of Nanotechnology for Precision Medicine focuses on the rational design of polymeric nanoconstructs for multi-modal imaging and combination therapy; fabrication of microfluidic chips for screening of nanomedicines; and development of hierarchical multi-scale computational models.

Prof. Stefano Gustincich

Stefano Gustincich is the coordinator of the Molecular Neuroscience line in MINDED and the director of the Laboratory of Non-coding RNAs and RNA-based Therapeutics at IIT. At the intersection of neurobiology and genome science, neurogenomics is the study of how the genome as a whole contributes to the evolution, development, structure, function and disease of the nervous system.

Prof. Cristina Becchio

Prof. Cristina Becchio is the coordinator of the Cognitive Neuroscience Robotics line in MINDED and the director of the Laboratory for Cognition, Motion and Neuroscience at IIT. The Cognition Motion and Neuroscience unit investigates the cognitive and neural mechanisms underlying motor cognition. To do this, we call upon a diverse array of research methods, including quantitative behavioural and neuroimaging techniques.

Prof. Agnieszka Wykowska

Agnieszka Wykowska is the coordinator of the Social Cognition in Human-Robot Interaction line in MINDED and the director of the Laboratory for Social Cognition in Human-Robot Interaction (S4HRI) at IIT.

Partners

European Medicines Agency

The European Medicines Agency (EMA) is a decentralized agency of the European Union (EU), located in London. It began operating in 1995 developed by pharmaceutical companies for use in the. The European Medicines Agency, is at the core of the European Union’s medicine and health system, and aims to protect human and animal health. The Agency is responsible for coordinating the European Medicines Regulatory Network in the scientific evaluation, supervision and safety monitoring of medicines: to ensure that the system works effectively, the Agency works closely with its partners and stakeholders, and is a proactive member of important networks in Europe and beyond. The Agency is interested in the emerging field of nanotechnology-based medicines, published a number of relevant scientific guidelines; and is active member of the International Pharmaceutical Regulators Forum and has a strong interest in collaborating with Academia and Research Institutions.

Universitat Pompeu Fabra

The advisor for this secondment will be Prof. Dr. Andrea Serino SNSF Professor at the University Hospital of Lausanne, Head of Neuroscience at MindMaze and Invited Professor at the Center for Neuroprosthetics of the EPFL. His main research topic is understanding the neural and cognitive basis of body and self experience in space. To this aim he has used multiple experimental techniques, both in healthy volunteers and in brain damaged patients, including psychophysics, non-invasive brain stimulation, fMRI, EEG and neural network modelling. Currently, he is working on how to apply such knowledge to develop virtual reality applications for rehabilitation after neuronal damage. Prof. Serino received in 2006 the De Renzi Prize from the Italian society of Neuropsychology and in 2016 the Leenaards Prize for translational research.

Centre Hospitalier Universitair Vaudois CHUV

The advisor for this secondment will be Prof. Dr. Andrea Serino SNSF Professor at the University Hospital of Lausanne, Head of Neuroscience at MindMaze and Invited Professor at the Center for Neuroprosthetics of the EPFL. His main research topic is understanding the neural and cognitive basis of body and self experience in space. To this aim he has used multiple experimental techniques, both in healthy volunteers and in brain damaged patients, including psychophysics, non-invasive brain stimulation, fMRI, EEG and neural network modelling. Currently, he is working on how to apply such knowledge to develop virtual reality applications for rehabilitation after neuronal damage. Prof. Serino received in 2006 the De Renzi Prize from the Italian society of Neuropsychology and in 2016 the Leenaards Prize for translational research.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 754490.
The content of this webiste is the sole responsibility of the authors. The European Commission or its services cannot be held responsible for any use that may be made of the information it contains.

© Minded Project